NEW YORK (GenomeWeb News) – Horizon Discovery said today it has received a share of a European Union Seventh Framework Programme grant totaling €5.75 million ($7.8 million) for work it will do on a project called "CV genes-at-target."

The grant was awarded to a consortium of research institutions and companies to study genomic risk loci for coronary artery disease and stroke in in vitro and in vivo settings and to determine whether they can serve as therapeutic targets.

Horizon did not specify how much of the grant it is receiving.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.